Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Top Cited Papers
Open Access
- 29 March 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (13) , 1304-1316
- https://doi.org/10.1056/nejmoa070635
Abstract
Levels of high-density lipoprotein (HDL) cholesterol are inversely related to cardiovascular risk. Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, increases HDL cholesterol levels, but the functional effects associated with this mechanism remain uncertain.Keywords
This publication has 29 references indexed in Scilit:
- The Failure of TorcetrapibArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density LipoproteinCholesterolLevelsonaBackgroundofAtorvastatinJournal of the American College of Cardiology, 2006
- Vascular Biomarkers and Surrogates in Cardiovascular DiseaseCirculation, 2006
- HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayJournal of Clinical Investigation, 2006
- The Forgotten MajorityJournal of the American College of Cardiology, 2005
- Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II DyslipidemiaThe American Journal of Cardiology, 2005
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2Circulation, 2004
- Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic LesionsCirculation, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of JapanArteriosclerosis, Thrombosis, and Vascular Biology, 1997